Oversold Conditions For Kailera Therapeutics (KLRA)
Published . Updated .
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Directly affected
- KLRA Kailera Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Re…
Source: Nasdaq Markets
The price since 2 Oct 2026: Kailera Therapeutics (KLRA) versus the S&P 500
Since the first closing price after “Oversold Conditions For Kailera Therapeutics (KLRA),” Kailera Therapeutics (KLRA) is +5.64%. The S&P 500 fund (SPY) is -1.08% over the same days, a +6.72% difference versus the market.
Who gains and who loses around Kailera Therapeutics (KLRA)
Companies tied to this story
- KLRA Kailera Therapeutics
In “Oversold Conditions For Kailera Therapeutics (KLRA),” Kailera Therapeutics (KLRA) is linked, with no stored direction, medium confidence. Reason on file: GA selected KLRA as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, kailera. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Oversold Conditions For Kailera Therapeutics (KLRA)” reaches Kailera Therapeutics (KLRA)
Kailera Therapeutics (KLRA) is the company in “Oversold Conditions For Kailera Therapeutics (KLRA),” the 2 Oct 2026 this story story.
Kailera Therapeutics (KLRA) is on the page because GA selected KLRA as a RELATED security because its canonical security name directly matches this event's themes: therapeutics, kailera. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for Kailera Therapeutics (KLRA), and the dates in the story
KLRA traded between 9.78 and 11.81 across 12 sessions. The latest close on file is 11.43.
How strong the case is around Kailera Therapeutics (KLRA)
14 out of 100
“Oversold Conditions For Kailera Therapeutics (KLRA)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.